Research Topics
Species | P M FlynnSummaryAffiliation: St. Jude Children's Research Hospital Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Catheter design influences recurrence of catheter-related bloodstream infection in children with cancerPatricia M Flynn
Department of Infectious Diseases, St Jude Children s Research Hospital, 332 N Lauderdale St, Memphis, TN 38105, USA
J Clin Oncol 21:3520-5. 2003....
Virologic and immunologic outcomes after 24 weeks in HIV type 1-infected adolescents receiving highly active antiretroviral therapyPatricia M Flynn
Department of Infectious Diseases, St Jude Children s Research Hospital, University of Tennessee Health Science Center, Memphis, Tennessee, USA
J Infect Dis 190:271-9. 2004..Adolescents represent the fastest growing demographic group of new human immunodeficiency virus (HIV) infections in the United States. At present, there is little information available about their response to therapy...
Pharmacokinetics and safety of single-dose tenofovir disoproxil fumarate and emtricitabine in HIV-1-infected pregnant women and their infantsPatricia M Flynn
St Jude Children s Research Hospital, Memphis, Tennessee 138105 2794, USA
Antimicrob Agents Chemother 55:5914-22. 2011..Rapidly decreasing TFV levels in infants suggest that multiple or higher doses of TDF will be necessary to maintain concentrations that are effective for viral suppression...
Long-term observation of adolescents initiating HAART therapy: three-year follow-upPatricia M Flynn
Department of Infectious Diseases, St Jude Children s Research Hospital, University of Tennessee Health Science Center, Memphis, Tennessee 38105, USA
AIDS Res Hum Retroviruses 23:1208-14. 2007..Interventions, especially those focused on adherence, are necessary to improve HAART outcomes in adolescents...
Intracellular pharmacokinetics of once versus twice daily zidovudine and lamivudine in adolescentsPatricia M Flynn
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, TN 38105, USA
Antimicrob Agents Chemother 51:3516-22. 2007..056). Although findings were similar between the BID and QD groups, the lower concentrations of ZDV and the number of patients below the level of detection after 24 h suggests that ZDV should continue to be administered BID...
Hepatitis B vaccination in HIV-infected youth: a randomized trial of three regimensPatricia M Flynn
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
J Acquir Immune Defic Syndr 56:325-32. 2011..HIV-infected youth are at risk of hepatitis B infection and should be vaccinated. Previous reports suggest reduced response to standard hepatitis B vaccine regimens...
Aspergillosis in children with cancer: A 34-year experienceS Abbasi
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
Clin Infect Dis 29:1210-9. 1999..0014). Aspergillosis continues to be associated with poor outcome. Development of improved medical and adjuvant therapies, including surgery, is warranted...
Systemic pharmacokinetics and cellular pharmacology of zidovudine in human immunodeficiency virus type 1-infected women and newborn infantsJ H Rodman
Pharmaceutical Sciences, St Jude Children s Research Hospital, Memphis, TN 38105, USA
J Infect Dis 180:1844-50. 1999..Studies of simpler oral regimens of zidovudine can now be evaluated regarding the ability to achieve these pharmacologic end points associated with highly effective parenteral therapy...
MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugsJ D Schuetz
Department of Pharmaceutical Sciences, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
Nat Med 5:1048-51. 1999..MRP4 is the first transporter, to our knowledge, directly linked to the efflux of nucleoside monophosphate analogs from mammalian cells...
Candidal meningitis in children with cancerJ A McCullers
Departments of Infectious Diseases and Virology and Molecular Biology, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
Clin Infect Dis 31:451-7. 2000..The cases were invariably fatal, supporting aggressive treatment of candidal meningitis in immunocompromised patients and further study of the prevention, diagnosis, and management of C. tropicalis meningitis...
Oral cefixime is similar to continued intravenous antibiotics in the empirical treatment of febrile neutropenic children with cancerJ L Shenep
Department of Infectious Diseases, St Jude Children s Research Hospital, University of Tennessee Health Sciences Center, Memphis, TN 38105, USA
Clin Infect Dis 32:36-43. 2001..0). Results support the safety of oral cefixime therapy for low-risk febrile neutropenic children, a therapeutic approach that would facilitate earlier outpatient management and decrease the costs of treatment...
Development of a directly observed therapy adherence intervention for adolescents with human immunodeficiency virus-1: application of focus group methodology to inform design, feasibility, and acceptabilityPatricia A Garvie
Division of Behavioral Medicine, St Jude Children s Research Hospital, Memphis, Tennessee, USA
J Adolesc Health 44:124-32. 2009..To obtain input from adolescents with human immunodeficiency virus-1 (HIV-1) infection to inform the design of a community-based modified directly observed therapy (MDOT) antiretroviral adherence intervention...
Etiology and clinical course of febrile neutropenia in children with cancerHana Hakim
Departments of Infectious Diseases, St Jude Children s Research Hospital, Memphis, TN 38105, USA
J Pediatr Hematol Oncol 31:623-9. 2009..The etiology, clinical course, and outcome of fever and neutropenia (FN) in children with cancer using the current FN guidelines and diagnostic resources in the United States have not been well described...
Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus infections in children with cancerAshok Srinivasan
Department of Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
Pediatr Blood Cancer 53:1216-20. 2009..However, the epidemiology of PVL-positive MRSA infections has not been described in children or adults with cancer...
Implementation of and barriers to routine HIV screening for adolescentsTimothy D Minniear
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
Pediatrics 124:1076-84. 2009..We developed and implemented a process for routine HIV screening, and we report screening practices and acceptance among adolescents at a large, urban, pediatric emergency department (ED)...
Staphylococcus aureus bacteremia in pediatric patients with cancerAshok Srinivasan
Department of Oncology, St Jude Children s Research Hospital, Memphis, TN 38105, USA
Pediatr Infect Dis J 29:172-4. 2010..Thirty-eight (73%) of the bacteremic episodes were catheter-related. Methicillin resistance was associated with increased catheter removal (P = 0.003), but no increase in complications or adverse outcomes was seen...
Risk prediction in pediatric cancer patients with fever and neutropeniaHana Hakim
Department of Infectious Diseases, Mail Stop 600, St Jude Children s Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105 3678, USA
Pediatr Infect Dis J 29:53-9. 2010..To identify predictors for 2 risk measures-"proven invasive bacterial infection or culture-negative sepsis (IBD)" and "clinical complications (CC)"-in pediatric cancer patients with fever and neutropenia (FN)...
Short communication: methicillin-resistant Staphylococcus aureus infections in children and young adults infected with HIVAshok Srinivasan
Department of Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
AIDS Res Hum Retroviruses 25:1219-24. 2009..PVL-positive MRSA infections were associated with more SSTI ( p=0.043) but not with increased morbidity or a higher risk of complications compared to PVL-negative MRSA infections in children and young adults with HIV...
Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virusJonathan A McCullers
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, Tennessee, USA
Clin Infect Dis 50:1487-92. 2010..Receipt of a vaccine to a related virus significantly enhanced the neutralization capacity of these responses, suggesting homologous vaccination against the 2009 pandemic H1N1 influenza virus would have a similar effect...
Efficacy and safety of cefepime in pediatric patients: a systematic review and meta-analysisElisabeth E Adderson
Department of Infectious Diseases, St Jude Children s Research Hospital, Department of Pediatrics, The University of Tennessee Health Sciences Center, Memphis TN 38105, USA
J Pediatr 157:490-5, 495.e1. 2010..We systematically reviewed clinical trials on the safety and efficacy of cefepime in pediatric patients in view of recent reports, which suggested that cefepime is associated with increased 30-day all-cause mortality rates...
Directly observed therapy (DOT) for nonadherent HIV-infected youth: lessons learned, challenges aheadAditya H Gaur
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
AIDS Res Hum Retroviruses 26:947-53. 2010..Depressed youth appear to be one subgroup that would benefit from this intervention. Study findings should help inform the design of larger community-based DOT intervention studies in youth...
Prophylaxis of Pneumocystis carinii pneumonia with atovaquone in children with leukemiaRenee M Madden
Division of Bone Marrow Transplantation, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
Cancer 109:1654-8. 2007..Therefore, a retrospective analysis was conducted to determine the incidence of PCP in pediatric patients who received prophylactic atovaquone during treatment for acute leukemia...
In situ diagnosis of central venous catheter-related bloodstream infection without peripheral blood cultureJeremy A Franklin
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, TN 38105, USA
Pediatr Infect Dis J 23:614-8. 2004..Comparative quantitative culture of blood obtained via the CVC and a peripheral vein (PV) is a well-accepted method of diagnosing CRBI; however, an alternative definition for use when a PV culture is not available is desirable...
Optimum management of pediatric patients with fever and neutropeniaAditya H Gaur
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
Indian J Pediatr 71:825-35. 2004..Selection of empiric antibiotics based on ongoing monitoring of antimicrobial susceptibility patterns is emphasized...
Newer treatments for fungal infectionsKatherine M Knapp
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, TN 38105, USA
J Support Oncol 3:290-8. 2005..The authors describe each of these new compounds and discuss how they fit into the overall management of fungal infections in patients with cancer...
Retrospective study of the safety of caspofungin in immunocompromised pediatric patientsJeremy A Franklin
Department of Infectious Diseases, St. Jude Children's Research Hospital, 332 N. Lauderdale Street, Memphis, TN 381205, USA
Pediatr Infect Dis J 22:747-9. 2003
Diagnosis of catheter-related bloodstream infections among pediatric oncology patients lacking a peripheral culture, using differential time to detectionAditya H Gaur
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
Pediatr Infect Dis J 24:445-9. 2005..Both the pain and inconvenience of PV cultures are undesirable...
Optimizing blood culture practices in pediatric immunocompromised patients: evaluation of media types and blood culture volumeAditya H Gaur
Department of Infectious Diseases, St. Jude Children's Research Hospital, University of Tennessee Health Science Center, 332 N. Lauderdale Street, Memphis, TN 38105-2794, USA
Pediatr Infect Dis J 22:545-52. 2003..0001). CONCLUSIONS: Optimal yield of blood cultures in immunocompromised pediatric patients included the use of BAC with a weight-based, graduated volume of culture inoculation and routine use of both AF and MFL...
Manifestations of fungal cellulitis of the orbit in children with neutropenia and feverMelanie L McCarty
Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, Tennessee, USA
Ophthal Plast Reconstr Surg 20:217-23. 2004..CONCLUSIONS: Because fungal orbital cellulitis can be fatal even if detected early in patients who are immunocompromised, ophthalmologists and otolaryngologists should be alert to the disease's subtle clinical manifestations...
The effect of atovaquone on etoposide pharmacokinetics in children with acute lymphoblastic leukemiaM E van de Poll
Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, TN 38105, USA
Cancer Chemother Pharmacol 47:467-72. 2001....
Bacillus cereus bacteremia and meningitis in immunocompromised childrenA H Gaur
Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105, USA
Clin Infect Dis 32:1456-62. 2001..cereus toxins...
Difference in time to detection: a simple method to differentiate catheter-related from non-catheter-related bloodstream infection in immunocompromised pediatric patientsAditya H Gaur
Department of Infectious Diseases, St. Jude Children's Research Hospital, University of Tennessee Health Science Center, Memphis, TN 38105-2794, USA
Clin Infect Dis 37:469-75. 2003....
Psychosocial profile of HIV-infected adolescents in a Southern US urban cohortH Kadivar
University of Tennessee Health Science Center, St. Jude Children's Research Hospital, Memphis, TN 38105, USA
AIDS Care 18:544-9. 2006..HIV-infected youth are best served in a comprehensive care environment with immediate access to medical care, social work, and psychology/psychiatry services...
Accuracy of percutaneous lung biopsy for invasive pulmonary aspergillosisF A Hoffer
Department of Diagnostic Imaging, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
Pediatr Radiol 31:144-52. 2001..Invasive pulmonary aspergillosis is fulminant and often fatal in immunosuppressed patients. Percutaneous biopsy may select patients who could benefit from surgical resection...
Efavirenz liquid formulation in human immunodeficiency virus-infected childrenStuart E Starr
Division of Infectious and Immunologic Diseases, Abramson Research Center, The Children s Hospital of Philadelphia, PA 19104, USA
Pediatr Infect Dis J 21:659-63. 2002....
Pharmacokinetics and safety of single oral doses of emtricitabine in human immunodeficiency virus-infected childrenLaurene H Wang
Triangle Pharmaceuticals, Inc, Gilead Sciences, Inc, Durham, North Carolina 27707, USA
Antimicrob Agents Chemother 48:183-91. 2004..e., median of approximately 10 h. micro g/ml). This pediatric FTC dose is being evaluated in long-term phase II therapeutic trials in HIV-infected children...
Relationship of plasma HIV-1 RNA dynamics to baseline factors and virological responses to highly active antiretroviral therapy in adolescents (aged 12-22 years) infected through high-risk behaviorHulin Wu
Department of Biostatistics and Computational Biology, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Rochester, NY 14642, USA
J Infect Dis 189:593-601. 2004....
Immunologic function and virologic suppression among children with perinatally acquired HIV Infection on highly active antiretroviral therapyRichard M Rutstein
Division of General Pediatrics, Children s Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA
Med Care 43:III15-22. 2005..Limited data are available on the level of virologic suppression and immune function of pediatric patients followed in clinical settings in the HAART era...
Hospital and outpatient health services utilization among HIV-infected children in care 2000-2001Richard M Rutstein
Division of General Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
Med Care 43:III31-9. 2005..Compared with prior studies, utilization rates appear to be declining over time. Unlike adults, racial/ethnic or gender disparities in healthcare utilization are less pronounced for HIV-infected children...
Immune reconstitution and predictors of virologic failure in adolescents infected through risk behaviors and initiating HAART: week 60 results from the PACTG 381 cohortBret J Rudy
Children s Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
AIDS Res Hum Retroviruses 22:213-21. 2006..Several T cell markers were predictive of subsequent virologic failure in subjects achieving short-term success. Further study is warranted to determine whether these predictors provide any benefit to clinical management...
Efficacy, safety and tolerability of tipranavir coadministered with ritonavir in HIV-1-infected children and adolescentsJuan C Salazar
Connecticut Children s Medical Center, University of Connecticut School of Medicine, Hartford, Connecticut 06106, USA
AIDS 22:1789-98. 2008..To evaluate the efficacy, safety and tolerability of ritonavir-boosted tipranavir (TPV/r) in HIV-1-infected pediatric patients...
Model for intracellular Lamivudine metabolism in peripheral blood mononuclear cells ex vivo and in human immunodeficiency virus type 1-infected adolescentsZexun Zhou
Department of Biomedical Engineering, University of Southern California, Los Angeles, CA 90089, USA
Antimicrob Agents Chemother 50:2686-94. 2006....
Ritonavir-based highly active antiretroviral therapy in human immunodeficiency virus type 1-infected infants younger than 24 months of ageEllen Gould Chadwick
Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
Pediatr Infect Dis J 24:793-800. 2005..Few data are available regarding clinical outcomes or dosing requirements for the protease inhibitor ritonavir in human immunodeficiency virus (HIV)-infected children younger than under 24 months of age...
Pharmacokinetics of antiretroviral regimens containing tenofovir disoproxil fumarate and atazanavir-ritonavir in adolescents and young adults with human immunodeficiency virus infectionJennifer J Kiser
University of Colorado at Denver and Health Sciences Center, Denver, CO, USA
Antimicrob Agents Chemother 52:631-7. 2008..Additional studies of the exposure-response relationships of this regimen in children, adolescents, and adults would advance our knowledge of its pharmacodynamic properties...
Analyses of HIV-1 drug-resistance profiles among infected adolescents experiencing delayed antiretroviral treatment switch after initial nonsuppressive highly active antiretroviral therapyAllison Agwu
Department of Pediatrics, Division of Infectious Diseases, Johns Hopkins Medical Institution, Baltimore, Maryland, USA
AIDS Patient Care STDS 22:545-52. 2008..This finding may have implications for initial treatment regimens and transmission risk in HIV-infected youth, a group with rising infection rates...
Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosisDavid W Denning
Education and Research Centre, Wythenshawe Hospital and University of Manchester, Academic Department of Medicine and Surgery, Southmoor Road, Manchester M23 9LT, UK
J Infect 53:337-49. 2006..This study evaluated the safety and efficacy of micafungin in patients with proven or probable invasive aspergillosis (IA)...
Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescentsThomas J Walsh
Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bldg 10 CRC, Room 1W 5750, 10 Center Drive, Bethesda, Maryland 20892, USA
Antimicrob Agents Chemother 49:4536-45. 2005..These results demonstrate that caspofungin at 1 mg/kg/day in pediatric patients is suboptimal. Caspofungin administration at 50 mg/m2/day provides a comparable exposure to that of adult patients treated with 50 mg/day...
Recruitment and retention of adolescent participants in HIV research: findings from the REACH (Reaching for Excellence in Adolescent Care and Health) ProjectPaulette D Stanford
University of Medicine and Dentistry of New Jersey, Newark, New Jersey 07103-2714, USA. stanfopd.umdnj.edu
J Adolesc Health 32:192-203. 2003..This study demonstrates that adolescents apply sound criteria in evaluating research participation and do not appear to be unduly affected by compensation...
Research Grants
- St. Jude/Memphis IMPAACT Clinical Trials UnitPatricia Flynn; Fiscal Year: 2007..administrative component: ..
- St. Jude-Memphis Adolescent Trials UnitPatricia Flynn; Fiscal Year: 2007..An ATU in Memphis would offer the combined advantages of an established, productive clinical research center with the proximity of a large at-risk population to maximize realization of the research efforts in the adolescent population. ..
- PEDIATRIC AIDS CLINICAL TRIALS GROUPPatricia Flynn; Fiscal Year: 2006..abstract_text> ..
